RAFFERTY ASSET MANAGEMENT, LLC – Alnylam Pharmaceuticals, Inc. Transaction History
RAFFERTY ASSET MANAGEMENT, LLC portfolio value:
$6.58M
portfolio value
RAFFERTY ASSET MANAGEMENT, LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.46% | 1.70K shares | 2.03M | $200.16 | 32.89K |
| Q2 2022 | share | Decrease | -15.78% | -5.84K shares | -1.49M | $145.85 | 31.19K |
| Q1 2022 | share | Increase | +15.93% | 5.09K shares | 630K | $163.29 | 37.03K |
| Q4 2021 | share | Increase | +94.43% | 15.51K shares | 2.31M | $171.03 | 31.94K |
| Q3 2021 | share | Increase | +3.93% | 621 shares | 422K | $188.81 | 16.43K |
| Q2 2021 | share | Decrease | -32.52% | -7.61K shares | -628K | $169.52 | 15.80K |
| Q1 2021 | share | Increase | +225.89% | 16.23K shares | 2.37M | $141.19 | 23.42K |
| Q4 2020 | share | Decrease | -55.64% | -9.01K shares | -1.42M | $129.97 | 7.18K |
| Q3 2020 | share | Increase | +62.99% | 6.26K shares | 887K | $145.6 | 16.20K |
| Q2 2020 | share | Increase | +143.70% | 5.86K shares | 1.02M | $148.11 | 9.94K |
| Q1 2020 | share | Decrease | -87.82% | -29.41K shares | -3.41M | $108.85 | 4.08K |
| Q4 2019 | share | Decrease | -56.85% | -44.13K shares | -2.38M | $115.17 | 33.49K |
| Q3 2019 | share | Increase | +9.69% | 6.85K shares | 1.10M | $80.42 | 77.63K |
| Q2 2019 | share | Increase | +18.50% | 11.05K shares | -445K | $72.56 | 70.77K |
| Q1 2019 | share | Increase | 0.00% | 59.72K shares | 5.58M | $93.45 | 59.72K |